P&T welcomes Dr. Baumel, the newest addition to our editorial board.
You are here
P&T® Journal contents for May 2003
The author reviews new warnings and label changes for sirolimus (Rapamune®), pergolide mesylate (Permax®), and salmeterol xinafoate inhalation aerosol (Serevent®).
A practicing physician relates the story of the best $4 he ever spent.
The authors present an in-depth review of Rebif® for prevention of relapses in patients with MS.
Determining the expenditures related to RSV infection requires diagnostic confirmation, a chart review, and an analysis of billing costs.
Dr. Prescott reviews drug-coated stents, beta blockade, a thrombin inhibitor, a new statin, a lipid-lowering formulation, and other advances presented at the ACC meeting.